Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results

Provided By Globe Newswire

Last update: Mar 3, 2022

Full-Year 2021 Revenue Increased 23% Year-Over-Year to $184.0 Million

Full-Year 2021 Net Income of $46.3 Million, or $0.26 Per Diluted Earnings Per Share